Rating History for Genmab (GMXAY) by BofA Securities

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/10/2018 Graham Perry Downgrade Underperform
(Buy)
N/A
(N/A)
16.49
(18.35)
11.28% Details